348 results
Challenging CTO interventions: part 3
07 Dec 2023 – From GulfPCR-GIM 2023
In this session, broaden your knowledge in CTO treatment by exploring these diverse cases: delve into the complexities of managing double CTO lesions with ACS, gain insights into the ambiguous ostium antegrade CTO, and explore effective techniques such as the semi stent crush technique for closing...
Complication cases - Best case submissions
06 Dec 2023 – From GulfPCR-GIM 2023
Benefit from a selection of 6 clinical cases whose complications are particularly interesting to discuss, including pericardial effusion following circumflex artery intervention, or Rota burr incarceration, to perfect your knowledge and gain tips and tricks to manage them better when you, in turn, come up against...
Uncommon causes of coronary ischaemia: expect the unexpected!
06 Dec 2023 – From GulfPCR-GIM 2023
Broaden your knowledge and learn about unusual causes of coronary ischaemia. Explore a variety of cases, including the discovery of a coronary fistula, how to diagnose coronary subclavian steal syndrome (CSSS), and more!
A new angiographic tool to evaluate stent expansion besides intracoronary imaging
24 Nov 2023
A 57-year-old man with hypertension and dyslipidemia as cardiovascular risk factors was admitted for stable angina for months. His symptoms were not controlled despite maximal medical treatment (beta-blockers, nitrates, aspirin, statins). Angios revealed multivessel disease. How would you manage this case?
Author
Dapagliflozin in acute myocardial infarction: Cardiometabolic benefits without impact on cardiovascular death or heart failure hospitalization: The jury is still out
14 Nov 2023
Luis Ortega Paz provides his take on DAPA-MI - A registry-based randomized trial of dapagliflozin in patient with acute myocardial infarction without diabetes, which was presented by Stefan James at AHA 2023 in Philadelphia.
Author
ORBITA-2 - Percutaneous coronary intervention for stable angina: A randomized, placebo-controlled trial
12 Nov 2023
Luis Ortega Paz interviews Rasha Al-Lamee and Christopher Rajkumar on the results of ORBITA-2 randomized placebo-controlled trial, which were presented at the AHA 2023 Congress in Philadelphia.
Author
Author
Author
AHA 2023: get the interventional cardiology perspective!
11 Nov 2023
Stay up to date with what is new and hot in interventional cardiology at #AHA23 in Philadelphia.
Guiding intervention for complex coronary lesions by optical coherence tomography or intravascular ultrasound
06 Nov 2023
The OCTIVUS trial was a prospective multicentre, open-label, randomised controlled trial comparing OCT guided PCI with IVUS guided PCI. In this pre-specified sub-study, the authors report the outcomes in patients with complex coronary lesions undergoing OCT- or IVUS-guided PCI.
Reviewer
Clopidogrel versus aspirin monotherapy beyond 1 year after PCI: STOPDAPT-2 five-year results
03 Nov 2023
The STOPDAPT-2 trial was a multicenter, open-label, adjudicator-blinded, randomised control trial comparing clopidogrel monotherapy after one-month DAPT with aspirin monotherapy following 12-months DAPT in patients undergoing PCI with a everolimus-eluting stent...
Reviewer
When should we perform PCI for stable coronary artery disease in aortic stenosis, pre, post, never?
17 May 2023 – From EuroPCR 2023
What is the evidence for the need for PCI in patients with stable coronary artery disease and severe aortic stenosis? Is invasive angiography always mandatory for these patients? What about CT scans? When exactly should PCI be performed?
These are the questions Vijay Kunadian and Martine Gilard...
